The stem cells from adipose tissue have a variety of uses, including research on stem cell differentiation, cell therapy, tissue engineering, and the creation of induced pluripotent stem cell lineages. These are rich in multipotent stem cells, adipocytes, osteocytes, chondrocytes, and other cell types can all be differentiated into adipocytes, osteocytes, and other cell types in vitro.

The global market for Adipose Tissue Derived Stem Cell was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Adipose Tissue Derived Stem Cell was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Adipose Tissue Derived Stem Cell was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Adipose Tissue Derived Stem Cell was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Adipose Tissue Derived Stem Cell include Lonza, ThermoFisher Scientific Inc, Celprogen, Inc, iXCells Biotechnologies, Merck KGaA, Lifeline Cell Technology, AlloCure, Inc, Antria, Inc and Celgene Corporation, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Adipose Tissue Derived Stem Cell, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Adipose Tissue Derived Stem Cell by region & country, by Type, and by Application.

The Adipose Tissue Derived Stem Cell market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adipose Tissue Derived Stem Cell.

Market Segmentation

Scope of Adipose Tissue Derived Stem Cell - Market Report

Report Metric	Details
Report Name	Adipose Tissue Derived Stem Cell - Market
Segment by Type:	Source of Human Fat Source of Animal Fat
Segment by Application	Regenerative Medicine Plastic Surgery Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, ThermoFisher Scientific Inc, Celprogen, Inc, iXCells Biotechnologies, Merck KGaA, Lifeline Cell Technology, AlloCure, Inc, Antria, Inc, Celgene Corporation, Cellleris SA, Corestem, Inc, Cytori Therapeutics, Inc, Intrexon, Inc, Mesoblast Ltd, Pluristem Therapeutics, Inc, Tissue Genesis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Adipose Tissue Derived Stem Cell manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Adipose Tissue Derived Stem Cell in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Adipose Tissue Derived Stem Cell in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Adipose Tissue Derived Stem Cell - Market report?

Ans: The main players in the Adipose Tissue Derived Stem Cell - Market are Lonza, ThermoFisher Scientific Inc, Celprogen, Inc, iXCells Biotechnologies, Merck KGaA, Lifeline Cell Technology, AlloCure, Inc, Antria, Inc, Celgene Corporation, Cellleris SA, Corestem, Inc, Cytori Therapeutics, Inc, Intrexon, Inc, Mesoblast Ltd, Pluristem Therapeutics, Inc, Tissue Genesis

What are the Application segmentation covered in the Adipose Tissue Derived Stem Cell - Market report?

Ans: The Applications covered in the Adipose Tissue Derived Stem Cell - Market report are Regenerative Medicine, Plastic Surgery, Other

What are the Type segmentation covered in the Adipose Tissue Derived Stem Cell - Market report?

Ans: The Types covered in the Adipose Tissue Derived Stem Cell - Market report are Source of Human Fat, Source of Animal Fat

1 Market Overview

1.1 Adipose Tissue Derived Stem Cell Product Introduction

1.2 Global Adipose Tissue Derived Stem Cell Market Size Forecast

1.2.1 Global Adipose Tissue Derived Stem Cell Sales Value (2019-2030)

1.2.2 Global Adipose Tissue Derived Stem Cell Sales Volume (2019-2030)

1.2.3 Global Adipose Tissue Derived Stem Cell Sales Price (2019-2030)

1.3 Adipose Tissue Derived Stem Cell Market Trends & Drivers

1.3.1 Adipose Tissue Derived Stem Cell Industry Trends

1.3.2 Adipose Tissue Derived Stem Cell Market Drivers & Opportunity

1.3.3 Adipose Tissue Derived Stem Cell Market Challenges

1.3.4 Adipose Tissue Derived Stem Cell Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Adipose Tissue Derived Stem Cell Players Revenue Ranking (2023)

2.2 Global Adipose Tissue Derived Stem Cell Revenue by Company (2019-2024)

2.3 Global Adipose Tissue Derived Stem Cell Players Sales Volume Ranking (2023)

2.4 Global Adipose Tissue Derived Stem Cell Sales Volume by Company Players (2019-2024)

2.5 Global Adipose Tissue Derived Stem Cell Average Price by Company (2019-2024)

2.6 Key Manufacturers Adipose Tissue Derived Stem Cell Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Adipose Tissue Derived Stem Cell Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Adipose Tissue Derived Stem Cell

2.9 Adipose Tissue Derived Stem Cell Market Competitive Analysis

2.9.1 Adipose Tissue Derived Stem Cell Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Adipose Tissue Derived Stem Cell Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adipose Tissue Derived Stem Cell as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Source of Human Fat

3.1.2 Source of Animal Fat

3.2 Global Adipose Tissue Derived Stem Cell Sales Value by Type

3.2.1 Global Adipose Tissue Derived Stem Cell Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Adipose Tissue Derived Stem Cell Sales Value, by Type (2019-2030)

3.2.3 Global Adipose Tissue Derived Stem Cell Sales Value, by Type (%) (2019-2030)

3.3 Global Adipose Tissue Derived Stem Cell Sales Volume by Type

3.3.1 Global Adipose Tissue Derived Stem Cell Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Adipose Tissue Derived Stem Cell Sales Volume, by Type (2019-2030)

3.3.3 Global Adipose Tissue Derived Stem Cell Sales Volume, by Type (%) (2019-2030)

3.4 Global Adipose Tissue Derived Stem Cell Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Regenerative Medicine

4.1.2 Plastic Surgery

4.1.3 Other

4.2 Global Adipose Tissue Derived Stem Cell Sales Value by Application

4.2.1 Global Adipose Tissue Derived Stem Cell Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Adipose Tissue Derived Stem Cell Sales Value, by Application (2019-2030)

4.2.3 Global Adipose Tissue Derived Stem Cell Sales Value, by Application (%) (2019-2030)

4.3 Global Adipose Tissue Derived Stem Cell Sales Volume by Application

4.3.1 Global Adipose Tissue Derived Stem Cell Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Adipose Tissue Derived Stem Cell Sales Volume, by Application (2019-2030)

4.3.3 Global Adipose Tissue Derived Stem Cell Sales Volume, by Application (%) (2019-2030)

4.4 Global Adipose Tissue Derived Stem Cell Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Adipose Tissue Derived Stem Cell Sales Value by Region

5.1.1 Global Adipose Tissue Derived Stem Cell Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Adipose Tissue Derived Stem Cell Sales Value by Region (2019-2024)

5.1.3 Global Adipose Tissue Derived Stem Cell Sales Value by Region (2025-2030)

5.1.4 Global Adipose Tissue Derived Stem Cell Sales Value by Region (%), (2019-2030)

5.2 Global Adipose Tissue Derived Stem Cell Sales Volume by Region

5.2.1 Global Adipose Tissue Derived Stem Cell Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Adipose Tissue Derived Stem Cell Sales Volume by Region (2019-2024)

5.2.3 Global Adipose Tissue Derived Stem Cell Sales Volume by Region (2025-2030)

5.2.4 Global Adipose Tissue Derived Stem Cell Sales Volume by Region (%), (2019-2030)

5.3 Global Adipose Tissue Derived Stem Cell Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

5.4.2 North America Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

5.5.2 Europe Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

5.6.2 Asia Pacific Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

5.7.2 South America Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

5.8.2 Middle East & Africa Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Value

6.2.1 Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.2.2 Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.3.2 United States Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Adipose Tissue Derived Stem Cell Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.4.2 Europe Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Adipose Tissue Derived Stem Cell Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.5.2 China Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

6.5.3 China Adipose Tissue Derived Stem Cell Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.6.2 Japan Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Adipose Tissue Derived Stem Cell Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.7.2 South Korea Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Adipose Tissue Derived Stem Cell Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.8.2 Southeast Asia Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Adipose Tissue Derived Stem Cell Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Adipose Tissue Derived Stem Cell Sales Value, 2019-2030

6.9.2 India Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

6.9.3 India Adipose Tissue Derived Stem Cell Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Lonza

7.1.1 Lonza Company Information

7.1.2 Lonza Introduction and Business Overview

7.1.3 Lonza Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Lonza Adipose Tissue Derived Stem Cell Product Offerings

7.1.5 Lonza Recent Development

7.2 ThermoFisher Scientific Inc

7.2.1 ThermoFisher Scientific Inc Company Information

7.2.2 ThermoFisher Scientific Inc Introduction and Business Overview

7.2.3 ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.2.4 ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Product Offerings

7.2.5 ThermoFisher Scientific Inc Recent Development

7.3 Celprogen, Inc

7.3.1 Celprogen, Inc Company Information

7.3.2 Celprogen, Inc Introduction and Business Overview

7.3.3 Celprogen, Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Celprogen, Inc Adipose Tissue Derived Stem Cell Product Offerings

7.3.5 Celprogen, Inc Recent Development

7.4 iXCells Biotechnologies

7.4.1 iXCells Biotechnologies Company Information

7.4.2 iXCells Biotechnologies Introduction and Business Overview

7.4.3 iXCells Biotechnologies Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.4.4 iXCells Biotechnologies Adipose Tissue Derived Stem Cell Product Offerings

7.4.5 iXCells Biotechnologies Recent Development

7.5 Merck KGaA

7.5.1 Merck KGaA Company Information

7.5.2 Merck KGaA Introduction and Business Overview

7.5.3 Merck KGaA Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Merck KGaA Adipose Tissue Derived Stem Cell Product Offerings

7.5.5 Merck KGaA Recent Development

7.6 Lifeline Cell Technology

7.6.1 Lifeline Cell Technology Company Information

7.6.2 Lifeline Cell Technology Introduction and Business Overview

7.6.3 Lifeline Cell Technology Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Lifeline Cell Technology Adipose Tissue Derived Stem Cell Product Offerings

7.6.5 Lifeline Cell Technology Recent Development

7.7 AlloCure, Inc

7.7.1 AlloCure, Inc Company Information

7.7.2 AlloCure, Inc Introduction and Business Overview

7.7.3 AlloCure, Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.7.4 AlloCure, Inc Adipose Tissue Derived Stem Cell Product Offerings

7.7.5 AlloCure, Inc Recent Development

7.8 Antria, Inc

7.8.1 Antria, Inc Company Information

7.8.2 Antria, Inc Introduction and Business Overview

7.8.3 Antria, Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Antria, Inc Adipose Tissue Derived Stem Cell Product Offerings

7.8.5 Antria, Inc Recent Development

7.9 Celgene Corporation

7.9.1 Celgene Corporation Company Information

7.9.2 Celgene Corporation Introduction and Business Overview

7.9.3 Celgene Corporation Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Celgene Corporation Adipose Tissue Derived Stem Cell Product Offerings

7.9.5 Celgene Corporation Recent Development

7.10 Cellleris SA

7.10.1 Cellleris SA Company Information

7.10.2 Cellleris SA Introduction and Business Overview

7.10.3 Cellleris SA Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Cellleris SA Adipose Tissue Derived Stem Cell Product Offerings

7.10.5 Cellleris SA Recent Development

7.11 Corestem, Inc

7.11.1 Corestem, Inc Company Information

7.11.2 Corestem, Inc Introduction and Business Overview

7.11.3 Corestem, Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Corestem, Inc Adipose Tissue Derived Stem Cell Product Offerings

7.11.5 Corestem, Inc Recent Development

7.12 Cytori Therapeutics, Inc

7.12.1 Cytori Therapeutics, Inc Company Information

7.12.2 Cytori Therapeutics, Inc Introduction and Business Overview

7.12.3 Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Product Offerings

7.12.5 Cytori Therapeutics, Inc Recent Development

7.13 Intrexon, Inc

7.13.1 Intrexon, Inc Company Information

7.13.2 Intrexon, Inc Introduction and Business Overview

7.13.3 Intrexon, Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Intrexon, Inc Adipose Tissue Derived Stem Cell Product Offerings

7.13.5 Intrexon, Inc Recent Development

7.14 Mesoblast Ltd

7.14.1 Mesoblast Ltd Company Information

7.14.2 Mesoblast Ltd Introduction and Business Overview

7.14.3 Mesoblast Ltd Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Mesoblast Ltd Adipose Tissue Derived Stem Cell Product Offerings

7.14.5 Mesoblast Ltd Recent Development

7.15 Pluristem Therapeutics, Inc

7.15.1 Pluristem Therapeutics, Inc Company Information

7.15.2 Pluristem Therapeutics, Inc Introduction and Business Overview

7.15.3 Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Product Offerings

7.15.5 Pluristem Therapeutics, Inc Recent Development

7.16 Tissue Genesis

7.16.1 Tissue Genesis Company Information

7.16.2 Tissue Genesis Introduction and Business Overview

7.16.3 Tissue Genesis Adipose Tissue Derived Stem Cell Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Tissue Genesis Adipose Tissue Derived Stem Cell Product Offerings

7.16.5 Tissue Genesis Recent Development

8 Industry Chain Analysis

8.1 Adipose Tissue Derived Stem Cell Industrial Chain

8.2 Adipose Tissue Derived Stem Cell Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Adipose Tissue Derived Stem Cell Sales Model

8.5.2 Sales Channel

8.5.3 Adipose Tissue Derived Stem Cell Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Lonza

Thermofisher Scientific, Inc.

Celprogen

iXCells Biotechnologies

Merck KGaA

Lifeline Cell Technology

Cytori Therapeutics Inc

Intrexon

Mesoblast Limited

Pluristem Therapeutics Inc

Tissue Genesis

Cellleris SA

List of Tables

Table 1. Adipose Tissue Derived Stem Cell Market Trends

Table 2. Adipose Tissue Derived Stem Cell Market Drivers & Opportunity

Table 3. Adipose Tissue Derived Stem Cell Market Challenges

Table 4. Adipose Tissue Derived Stem Cell Market Restraints

Table 5. Global Adipose Tissue Derived Stem Cell Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Adipose Tissue Derived Stem Cell Revenue Market Share by Company (2019-2024)

Table 7. Global Adipose Tissue Derived Stem Cell Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Adipose Tissue Derived Stem Cell Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Adipose Tissue Derived Stem Cell Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Adipose Tissue Derived Stem Cell Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Adipose Tissue Derived Stem Cell Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Adipose Tissue Derived Stem Cell

Table 13. Global Adipose Tissue Derived Stem Cell Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adipose Tissue Derived Stem Cell as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Adipose Tissue Derived Stem Cell Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Adipose Tissue Derived Stem Cell Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Adipose Tissue Derived Stem Cell Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Adipose Tissue Derived Stem Cell Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Adipose Tissue Derived Stem Cell Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Adipose Tissue Derived Stem Cell Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Adipose Tissue Derived Stem Cell Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Adipose Tissue Derived Stem Cell Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Adipose Tissue Derived Stem Cell Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Adipose Tissue Derived Stem Cell Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Adipose Tissue Derived Stem Cell Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Adipose Tissue Derived Stem Cell Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Adipose Tissue Derived Stem Cell Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Adipose Tissue Derived Stem Cell Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Adipose Tissue Derived Stem Cell Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Adipose Tissue Derived Stem Cell Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Adipose Tissue Derived Stem Cell Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Adipose Tissue Derived Stem Cell Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Adipose Tissue Derived Stem Cell Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Adipose Tissue Derived Stem Cell Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Adipose Tissue Derived Stem Cell Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Adipose Tissue Derived Stem Cell Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Adipose Tissue Derived Stem Cell Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Adipose Tissue Derived Stem Cell Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Adipose Tissue Derived Stem Cell Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Adipose Tissue Derived Stem Cell Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Adipose Tissue Derived Stem Cell Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Adipose Tissue Derived Stem Cell Sales Value by Region (2019-2024) & (%)

Table 44. Global Adipose Tissue Derived Stem Cell Sales Value by Region (2025-2030) & (%)

Table 45. Global Adipose Tissue Derived Stem Cell Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Adipose Tissue Derived Stem Cell Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Adipose Tissue Derived Stem Cell Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Adipose Tissue Derived Stem Cell Sales Volume by Region (2019-2024) & (%)

Table 49. Global Adipose Tissue Derived Stem Cell Sales Volume by Region (2025-2030) & (%)

Table 50. Global Adipose Tissue Derived Stem Cell Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Adipose Tissue Derived Stem Cell Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Volume, (2025-2030) & (K Units)

Table 57. Lonza Company Information

Table 58. Lonza Introduction and Business Overview

Table 59. Lonza Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Lonza Adipose Tissue Derived Stem Cell Product Offerings

Table 61. Lonza Recent Development

Table 62. ThermoFisher Scientific Inc Company Information

Table 63. ThermoFisher Scientific Inc Introduction and Business Overview

Table 64. ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. ThermoFisher Scientific Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 66. ThermoFisher Scientific Inc Recent Development

Table 67. Celprogen, Inc Company Information

Table 68. Celprogen, Inc Introduction and Business Overview

Table 69. Celprogen, Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Celprogen, Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 71. Celprogen, Inc Recent Development

Table 72. iXCells Biotechnologies Company Information

Table 73. iXCells Biotechnologies Introduction and Business Overview

Table 74. iXCells Biotechnologies Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. iXCells Biotechnologies Adipose Tissue Derived Stem Cell Product Offerings

Table 76. iXCells Biotechnologies Recent Development

Table 77. Merck KGaA Company Information

Table 78. Merck KGaA Introduction and Business Overview

Table 79. Merck KGaA Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Merck KGaA Adipose Tissue Derived Stem Cell Product Offerings

Table 81. Merck KGaA Recent Development

Table 82. Lifeline Cell Technology Company Information

Table 83. Lifeline Cell Technology Introduction and Business Overview

Table 84. Lifeline Cell Technology Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Lifeline Cell Technology Adipose Tissue Derived Stem Cell Product Offerings

Table 86. Lifeline Cell Technology Recent Development

Table 87. AlloCure, Inc Company Information

Table 88. AlloCure, Inc Introduction and Business Overview

Table 89. AlloCure, Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. AlloCure, Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 91. AlloCure, Inc Recent Development

Table 92. Antria, Inc Company Information

Table 93. Antria, Inc Introduction and Business Overview

Table 94. Antria, Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Antria, Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 96. Antria, Inc Recent Development

Table 97. Celgene Corporation Company Information

Table 98. Celgene Corporation Introduction and Business Overview

Table 99. Celgene Corporation Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Celgene Corporation Adipose Tissue Derived Stem Cell Product Offerings

Table 101. Celgene Corporation Recent Development

Table 102. Cellleris SA Company Information

Table 103. Cellleris SA Introduction and Business Overview

Table 104. Cellleris SA Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Cellleris SA Adipose Tissue Derived Stem Cell Product Offerings

Table 106. Cellleris SA Recent Development

Table 107. Corestem, Inc Company Information

Table 108. Corestem, Inc Introduction and Business Overview

Table 109. Corestem, Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Corestem, Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 111. Corestem, Inc Recent Development

Table 112. Cytori Therapeutics, Inc Company Information

Table 113. Cytori Therapeutics, Inc Introduction and Business Overview

Table 114. Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Cytori Therapeutics, Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 116. Cytori Therapeutics, Inc Recent Development

Table 117. Intrexon, Inc Company Information

Table 118. Intrexon, Inc Introduction and Business Overview

Table 119. Intrexon, Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Intrexon, Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 121. Intrexon, Inc Recent Development

Table 122. Mesoblast Ltd Company Information

Table 123. Mesoblast Ltd Introduction and Business Overview

Table 124. Mesoblast Ltd Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Mesoblast Ltd Adipose Tissue Derived Stem Cell Product Offerings

Table 126. Mesoblast Ltd Recent Development

Table 127. Pluristem Therapeutics, Inc Company Information

Table 128. Pluristem Therapeutics, Inc Introduction and Business Overview

Table 129. Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Pluristem Therapeutics, Inc Adipose Tissue Derived Stem Cell Product Offerings

Table 131. Pluristem Therapeutics, Inc Recent Development

Table 132. Tissue Genesis Company Information

Table 133. Tissue Genesis Introduction and Business Overview

Table 134. Tissue Genesis Adipose Tissue Derived Stem Cell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Tissue Genesis Adipose Tissue Derived Stem Cell Product Offerings

Table 136. Tissue Genesis Recent Development

Table 137. Key Raw Materials Lists

Table 138. Raw Materials Key Suppliers Lists

Table 139. Adipose Tissue Derived Stem Cell Downstream Customers

Table 140. Adipose Tissue Derived Stem Cell Distributors List

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Adipose Tissue Derived Stem Cell Product Picture

Figure 2. Global Adipose Tissue Derived Stem Cell Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Adipose Tissue Derived Stem Cell Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Adipose Tissue Derived Stem Cell Sales Volume (2019-2030) & (K Units)

Figure 5. Global Adipose Tissue Derived Stem Cell Sales Price (2019-2030) & (US$/Unit)

Figure 6. Adipose Tissue Derived Stem Cell Report Years Considered

Figure 7. Global Adipose Tissue Derived Stem Cell Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Adipose Tissue Derived Stem Cell Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Adipose Tissue Derived Stem Cell Revenue in 2023

Figure 10. Adipose Tissue Derived Stem Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Source of Human Fat Picture

Figure 12. Source of Animal Fat Picture

Figure 13. Global Adipose Tissue Derived Stem Cell Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Adipose Tissue Derived Stem Cell Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Adipose Tissue Derived Stem Cell Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Adipose Tissue Derived Stem Cell Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Adipose Tissue Derived Stem Cell Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Regenerative Medicine

Figure 19. Product Picture of Plastic Surgery

Figure 20. Product Picture of Other

Figure 21. Global Adipose Tissue Derived Stem Cell Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Adipose Tissue Derived Stem Cell Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Adipose Tissue Derived Stem Cell Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Adipose Tissue Derived Stem Cell Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Adipose Tissue Derived Stem Cell Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Adipose Tissue Derived Stem Cell Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Adipose Tissue Derived Stem Cell Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Adipose Tissue Derived Stem Cell Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Adipose Tissue Derived Stem Cell Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Adipose Tissue Derived Stem Cell Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Adipose Tissue Derived Stem Cell Sales Volume (%), (2019-2030)

Figure 38. United States Adipose Tissue Derived Stem Cell Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Adipose Tissue Derived Stem Cell Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Adipose Tissue Derived Stem Cell Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Adipose Tissue Derived Stem Cell Sales Value by Application (%), 2023 VS 2030

Figure 44. China Adipose Tissue Derived Stem Cell Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

Figure 46. China Adipose Tissue Derived Stem Cell Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Adipose Tissue Derived Stem Cell Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Adipose Tissue Derived Stem Cell Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Adipose Tissue Derived Stem Cell Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Adipose Tissue Derived Stem Cell Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Adipose Tissue Derived Stem Cell Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Adipose Tissue Derived Stem Cell Sales Value by Application (%), 2023 VS 2030

Figure 56. India Adipose Tissue Derived Stem Cell Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Adipose Tissue Derived Stem Cell Sales Value by Type (%), 2023 VS 2030

Figure 58. India Adipose Tissue Derived Stem Cell Sales Value by Application (%), 2023 VS 2030

Figure 59. Adipose Tissue Derived Stem Cell Industrial Chain

Figure 60. Adipose Tissue Derived Stem Cell Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions